Disagreement on cancer drug decisions in Europe.

International Journal of Technology Assessment in Health Care
Laia Maynou, John Cairns

Abstract

Despite the efforts of the European Union (EU) to promote voluntary cooperation among Health Technology Assessment (HTA) agencies, different reimbursement decisions for the same drug are made across European countries. The aim of this paper is to compare the agreement of cancer drug reimbursement decisions using inter-rater reliability measures. This study is based on primary data on 161 cancer drug reimbursement decisions from nine European countries from 2002 to 2014. To achieve our goal, we use two measures to analyze agreement, in other words, congruency: (i) percentage of agreement and (ii) the κ score. One main conclusion can be drawn from the analysis. There is a weak to medium agreement among cancer drug decisions in the European countries analyzed (based on the percentage of agreement and the κ score). England and Scotland show the highest consistency between the two measures, showing a medium agreement. These results are in line with previous literature on the congruency of HTA decisions. This paper contributes to the HTA literature, by highlighting the extent of weak to medium agreement among cancer decisions in Europe.

References

Jan 1, 1990·Journal of Clinical Epidemiology·A R Feinstein, D V Cicchetti
Oct 11, 2005·Health Policy·Helen Angela DakinIsaac A O Odeyemi
Oct 8, 2009·JAMA : the Journal of the American Medical Association·Fiona M ClementBraden J Manns
Sep 20, 2012·International Journal of Technology Assessment in Health Care·Margreet FrankenMarc Koopmanschap
May 22, 2013·Health Economics, Policy, and Law·Karin H CerriJose-Luis Fernandez
Jan 21, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lianne BarniehFiona Clement
Sep 25, 2014·Health Economics·Helen DakinDavid Parkin
Dec 4, 2014·Pharmaceutical Statistics·Laura Flight, Steven A Julious
Mar 17, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mata CharokopouBart Heeg
Mar 16, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nicola AllenSam Salek
Oct 2, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Wija OortwijnJeroen van der Tuin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
N Schoenherr, J Gordon
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Ronald L AkehurstFrançois Sarkozy
Annals of Oncology : Official Journal of the European Society for Medical Oncology
T HwangA Kesselheim
International Journal of Technology Assessment in Health Care
David BantaEgon Jonsson
© 2022 Meta ULC. All rights reserved